My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
December 2008
Vol. 18 No. 12
Education and Resources
New HIV/TB Funding Available
David Bryden

A new source of product development funding has opened up for HIV, TB, and other neglected diseases.  The United Kingdom's Department for International development (DFID) has announced a new $300 million fund for public-private partnerships to develop drugs, vaccines, and other technologies for priority diseases. The fund is open to researchers from any country. Applications for the next round will open in early January, and details will be posted on the DFID website. For more information, to sign up for alerts, or to view the application form for the previous round, visit the DFID website.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Top Stories
Guideline on Fever/Infection in Long-Term Care Facilities Updated
IDSA Journal Club, December 2008
Patient Care and Science
EIN: Vancomycin for Pacer Prophylaxis?
In the IDSA Journals
Practice Management
Get Paid for Reporting Quality Indicators–While It’s Still Voluntary
Online Tools Can Help You Estimate Your Medicare Payments
Policy and Advocacy
IDSA Year-end Advocacy Wrap-up
Your Colleagues
Members on the Move
Welcome, New IDSA Members!
Education and Resources
Influenza Resources from IDSA and CIDRAP
Looking For A New Job or Employee?
New HIV/TB Funding Available
Apply Now for the 2009 Joint Research Awards

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.